EyeConic: Qualification for Cone-Optogenetics

Part of paid clinical trials in San Francisco, California.

Sponsor
Institute of Molecular and Clinical Ophthalmology Basel
Study ID
NCT05294978
Status
Recruiting
Apply to this trial

Conditions

  • Retinal Dystrophies

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • Optical coherence tomography (OCT) — DIAGNOSTIC_TEST
    Data of macular optical coherence tomography (OCT)

Study Details

This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.

Key Dates

Start date
Jul 1, 2021
Status verified
Jul 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Patients
    -Availability of macular optical coherence tomography (OCT)
  • Arm: Controls
    -Availability of macular optical coherence tomography (OCT)

Primary Outcome Measure

OCT - Central retinal volume [ Time Frame: Baseline (about 10 minutes) ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
University of California San Francisco, Department of OphthalmologySan FranciscoCalifornia94158
Jacque Duncan, MD (PRINCIPAL_INVESTIGATOR)
Bascom Palmer Eye InstituteMiamiFlorida33136
Byron L Lam, MD (PRINCIPAL_INVESTIGATOR)
Potyra Rosa, MD (SUB_INVESTIGATOR)
University of Pittsburgh, Department of OphthalmologyPittsburghPennsylvania15213
Jose A Sahel, MD (PRINCIPAL_INVESTIGATOR)
Boris Rosin, MD (SUB_INVESTIGATOR)
Michelle Alabek, MD (SUB_INVESTIGATOR)

Find similar trials in San Francisco, CA

By research site
University of California San Francisco, Department of Ophthalmology· San Francisco, CABascom Palmer Eye Institute· Miami, FLUniversity of Pittsburgh, Department of Ophthalmology· Pittsburgh, PA

Related Studies